| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parenteral Nutrition, Total | 116 | 2014 | 304 | 8.120 |
Why?
|
| Parenteral Nutrition | 74 | 2024 | 663 | 7.570 |
Why?
|
| Fat Emulsions, Intravenous | 48 | 2020 | 314 | 5.290 |
Why?
|
| Enteral Nutrition | 58 | 2024 | 802 | 4.980 |
Why?
|
| Protein-Energy Malnutrition | 51 | 2017 | 189 | 4.390 |
Why?
|
| Critical Illness | 30 | 2020 | 2753 | 3.240 |
Why?
|
| Fatty Acids, Essential | 20 | 2017 | 97 | 2.970 |
Why?
|
| Fish Oils | 39 | 2020 | 483 | 2.790 |
Why?
|
| Nutritional Support | 14 | 2022 | 178 | 2.770 |
Why?
|
| Triglycerides | 56 | 2024 | 2444 | 2.570 |
Why?
|
| Fatty Acids, Omega-3 | 21 | 2024 | 1399 | 2.540 |
Why?
|
| Eicosapentaenoic Acid | 13 | 2024 | 565 | 1.990 |
Why?
|
| Arachidonic Acid | 18 | 2017 | 430 | 1.960 |
Why?
|
| Docosahexaenoic Acids | 15 | 2021 | 914 | 1.860 |
Why?
|
| Dietary Proteins | 47 | 2014 | 960 | 1.760 |
Why?
|
| Phospholipids | 30 | 2013 | 778 | 1.720 |
Why?
|
| Nutritional Status | 14 | 2023 | 1628 | 1.710 |
Why?
|
| Hyperglycemia | 14 | 2011 | 1388 | 1.680 |
Why?
|
| Energy Metabolism | 50 | 2019 | 2906 | 1.530 |
Why?
|
| Liver | 80 | 2015 | 7578 | 1.530 |
Why?
|
| Blood Glucose | 42 | 2023 | 6421 | 1.430 |
Why?
|
| Dietary Fats | 32 | 2013 | 2001 | 1.400 |
Why?
|
| Nutritional Sciences | 8 | 2017 | 148 | 1.400 |
Why?
|
| Fatty Acids | 31 | 2013 | 1806 | 1.310 |
Why?
|
| Nutrition Assessment | 6 | 2020 | 740 | 1.290 |
Why?
|
| Glucose | 35 | 2023 | 4341 | 1.220 |
Why?
|
| Nutrition Disorders | 20 | 2012 | 204 | 1.180 |
Why?
|
| Plant Oils | 12 | 2015 | 199 | 1.180 |
Why?
|
| Interleukin-1 | 26 | 2004 | 1252 | 1.170 |
Why?
|
| Endotoxins | 16 | 2011 | 519 | 1.140 |
Why?
|
| Cachexia | 9 | 2020 | 202 | 1.110 |
Why?
|
| Critical Care | 23 | 2022 | 2714 | 1.090 |
Why?
|
| Energy Intake | 47 | 2023 | 2145 | 1.090 |
Why?
|
| Amino Acids | 49 | 2022 | 1712 | 1.090 |
Why?
|
| Systemic Inflammatory Response Syndrome | 9 | 2009 | 621 | 1.090 |
Why?
|
| Drug Stability | 18 | 2024 | 289 | 1.060 |
Why?
|
| Insulin | 35 | 2011 | 6602 | 1.050 |
Why?
|
| Food, Formulated | 19 | 2010 | 103 | 1.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 27 | 2019 | 4349 | 0.990 |
Why?
|
| Proteins | 69 | 2023 | 6001 | 0.980 |
Why?
|
| Particle Size | 16 | 2024 | 1633 | 0.960 |
Why?
|
| Rats, Sprague-Dawley | 55 | 2012 | 8108 | 0.940 |
Why?
|
| Rats | 119 | 2017 | 23713 | 0.920 |
Why?
|
| Lipids | 16 | 2024 | 3322 | 0.910 |
Why?
|
| gamma-Linolenic Acid | 7 | 2012 | 16 | 0.900 |
Why?
|
| Nutritional Requirements | 20 | 2017 | 279 | 0.860 |
Why?
|
| Dietary Fats, Unsaturated | 7 | 2015 | 222 | 0.850 |
Why?
|
| Wasting Syndrome | 4 | 2014 | 96 | 0.800 |
Why?
|
| Soybean Oil | 8 | 2015 | 139 | 0.780 |
Why?
|
| Serum Albumin | 32 | 2023 | 676 | 0.770 |
Why?
|
| Erythromycin | 2 | 2012 | 114 | 0.760 |
Why?
|
| Inflammation | 17 | 2024 | 10869 | 0.750 |
Why?
|
| Intestine, Small | 7 | 2012 | 1217 | 0.740 |
Why?
|
| Food | 6 | 2009 | 766 | 0.740 |
Why?
|
| Antioxidants | 5 | 2013 | 1671 | 0.710 |
Why?
|
| Plastics | 4 | 2009 | 117 | 0.710 |
Why?
|
| Nitrogen | 50 | 1997 | 344 | 0.700 |
Why?
|
| Postoperative Care | 16 | 2010 | 1480 | 0.690 |
Why?
|
| Acute Lung Injury | 2 | 2016 | 377 | 0.690 |
Why?
|
| Diet, Fat-Restricted | 3 | 2012 | 328 | 0.650 |
Why?
|
| Interleukin-6 | 13 | 2019 | 3227 | 0.650 |
Why?
|
| Fatty Acids, Nonesterified | 13 | 2012 | 393 | 0.640 |
Why?
|
| Liver Diseases | 16 | 2003 | 1304 | 0.630 |
Why?
|
| Lipid Metabolism | 16 | 2012 | 1895 | 0.610 |
Why?
|
| Humans | 382 | 2024 | 767040 | 0.610 |
Why?
|
| C-Reactive Protein | 10 | 2018 | 3851 | 0.610 |
Why?
|
| Malnutrition | 2 | 2023 | 632 | 0.590 |
Why?
|
| Insulin-Like Growth Factor I | 9 | 2000 | 1939 | 0.580 |
Why?
|
| Oxidative Stress | 8 | 2013 | 3139 | 0.570 |
Why?
|
| Emulsions | 7 | 2024 | 150 | 0.570 |
Why?
|
| Obesity | 41 | 2019 | 13085 | 0.560 |
Why?
|
| Mononuclear Phagocyte System | 7 | 2006 | 55 | 0.560 |
Why?
|
| Body Height | 13 | 2020 | 1565 | 0.550 |
Why?
|
| alpha-Linolenic Acid | 7 | 2017 | 144 | 0.550 |
Why?
|
| Wounds and Injuries | 17 | 2022 | 2513 | 0.540 |
Why?
|
| Parenteral Nutrition Solutions | 3 | 2013 | 30 | 0.540 |
Why?
|
| Ketone Bodies | 9 | 2015 | 76 | 0.540 |
Why?
|
| Deficiency Diseases | 3 | 2015 | 74 | 0.540 |
Why?
|
| Parenteral Nutrition, Home Total | 5 | 2002 | 9 | 0.540 |
Why?
|
| Hypoglycemic Agents | 4 | 2011 | 3108 | 0.530 |
Why?
|
| Linoleic Acid | 9 | 2017 | 158 | 0.520 |
Why?
|
| Ketosis | 5 | 2015 | 46 | 0.520 |
Why?
|
| Hypoglycemia | 4 | 2011 | 896 | 0.500 |
Why?
|
| Caloric Restriction | 3 | 2013 | 302 | 0.490 |
Why?
|
| Ventilator Weaning | 5 | 2012 | 170 | 0.490 |
Why?
|
| Anemia, Iron-Deficiency | 5 | 2002 | 372 | 0.490 |
Why?
|
| Muscles | 28 | 1998 | 1576 | 0.490 |
Why?
|
| Phosphates | 5 | 2012 | 765 | 0.490 |
Why?
|
| Leucine | 38 | 1997 | 547 | 0.490 |
Why?
|
| Drug Packaging | 4 | 2009 | 44 | 0.480 |
Why?
|
| Endotoxemia | 4 | 2019 | 198 | 0.480 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2015 | 81 | 0.480 |
Why?
|
| Intensive Care Units | 12 | 2023 | 3797 | 0.470 |
Why?
|
| Infusions, Parenteral | 12 | 2007 | 395 | 0.460 |
Why?
|
| Diet, Carbohydrate-Restricted | 2 | 2018 | 263 | 0.460 |
Why?
|
| Animals | 164 | 2024 | 168965 | 0.450 |
Why?
|
| Male | 256 | 2022 | 364203 | 0.450 |
Why?
|
| Diet, Protein-Restricted | 3 | 2012 | 73 | 0.450 |
Why?
|
| Rats, Inbred Strains | 43 | 1992 | 2078 | 0.450 |
Why?
|
| Random Allocation | 19 | 2009 | 2394 | 0.440 |
Why?
|
| Respiration, Artificial | 7 | 2013 | 2726 | 0.440 |
Why?
|
| Body Weight | 56 | 2012 | 4627 | 0.440 |
Why?
|
| Dry Eye Syndromes | 1 | 2018 | 385 | 0.440 |
Why?
|
| Protein Deficiency | 7 | 1998 | 57 | 0.430 |
Why?
|
| Intestinal Absorption | 3 | 2012 | 400 | 0.430 |
Why?
|
| Fasting | 25 | 1997 | 1607 | 0.430 |
Why?
|
| Safflower Oil | 11 | 2001 | 29 | 0.420 |
Why?
|
| Liver Transplantation | 17 | 2007 | 2416 | 0.420 |
Why?
|
| Carbohydrate Metabolism | 6 | 2012 | 261 | 0.420 |
Why?
|
| Carcinoma 256, Walker | 6 | 1995 | 37 | 0.410 |
Why?
|
| Glass | 3 | 2007 | 116 | 0.410 |
Why?
|
| Electrolytes | 3 | 2012 | 279 | 0.410 |
Why?
|
| Calcium Chloride | 1 | 2012 | 78 | 0.410 |
Why?
|
| Nutritional Physiological Phenomena | 13 | 2013 | 360 | 0.410 |
Why?
|
| Diet | 20 | 2012 | 8089 | 0.400 |
Why?
|
| Nanoparticles | 1 | 2024 | 1966 | 0.400 |
Why?
|
| Fatty Acids, Unsaturated | 7 | 2012 | 541 | 0.400 |
Why?
|
| Muscle, Skeletal | 9 | 2014 | 4968 | 0.390 |
Why?
|
| Symporters | 1 | 2015 | 363 | 0.390 |
Why?
|
| Nutritive Value | 3 | 2012 | 351 | 0.390 |
Why?
|
| Dietary Supplements | 13 | 2018 | 3446 | 0.390 |
Why?
|
| Weight Loss | 9 | 2018 | 2716 | 0.390 |
Why?
|
| Aluminum | 1 | 2012 | 150 | 0.390 |
Why?
|
| Acute-Phase Reaction | 4 | 2004 | 91 | 0.380 |
Why?
|
| Liver Failure | 4 | 2001 | 252 | 0.380 |
Why?
|
| Short Bowel Syndrome | 9 | 2011 | 352 | 0.380 |
Why?
|
| Kidney Failure, Chronic | 11 | 2000 | 2495 | 0.370 |
Why?
|
| Solanum tuberosum | 1 | 2011 | 47 | 0.370 |
Why?
|
| Gastrointestinal Transit | 1 | 2012 | 102 | 0.370 |
Why?
|
| Malabsorption Syndromes | 3 | 2010 | 135 | 0.370 |
Why?
|
| Stress, Physiological | 14 | 2003 | 1407 | 0.360 |
Why?
|
| Adjuvants, Immunologic | 4 | 2006 | 998 | 0.360 |
Why?
|
| Immune System | 4 | 2004 | 799 | 0.360 |
Why?
|
| Weight Gain | 10 | 2014 | 2360 | 0.360 |
Why?
|
| Multiple Organ Failure | 2 | 2013 | 389 | 0.360 |
Why?
|
| Food, Fortified | 4 | 2010 | 189 | 0.360 |
Why?
|
| Yogurt | 1 | 2010 | 71 | 0.360 |
Why?
|
| Sepsis | 13 | 2015 | 2605 | 0.350 |
Why?
|
| Burns | 13 | 2002 | 1902 | 0.350 |
Why?
|
| Macrophages, Alveolar | 6 | 1999 | 413 | 0.350 |
Why?
|
| Glutamine | 1 | 2013 | 575 | 0.350 |
Why?
|
| Fisheries | 1 | 2010 | 48 | 0.340 |
Why?
|
| Immunity | 5 | 2012 | 1002 | 0.340 |
Why?
|
| Hyperinsulinism | 2 | 2007 | 402 | 0.340 |
Why?
|
| Practice Guidelines as Topic | 5 | 2017 | 7435 | 0.330 |
Why?
|
| Catheterization, Central Venous | 8 | 1998 | 537 | 0.330 |
Why?
|
| Fishes | 2 | 2010 | 607 | 0.320 |
Why?
|
| Evidence-Based Medicine | 3 | 2017 | 3700 | 0.320 |
Why?
|
| Solutions | 6 | 2006 | 405 | 0.320 |
Why?
|
| Cross Infection | 4 | 2000 | 1426 | 0.310 |
Why?
|
| Hypertriglyceridemia | 2 | 2009 | 293 | 0.310 |
Why?
|
| Dietary Carbohydrates | 14 | 2012 | 896 | 0.310 |
Why?
|
| Sarcoma, Yoshida | 4 | 1992 | 11 | 0.300 |
Why?
|
| Eicosanoids | 3 | 1999 | 284 | 0.300 |
Why?
|
| Creatinine | 10 | 2023 | 1916 | 0.290 |
Why?
|
| Vitamin B Complex | 1 | 2010 | 299 | 0.290 |
Why?
|
| Cytokines | 9 | 2005 | 7446 | 0.290 |
Why?
|
| Food Contamination | 1 | 2009 | 193 | 0.290 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2003 | 1244 | 0.290 |
Why?
|
| Diabetes Mellitus, Type 1 | 7 | 2018 | 3449 | 0.290 |
Why?
|
| Research Design | 5 | 2020 | 6210 | 0.280 |
Why?
|
| Amino Acids, Branched-Chain | 11 | 1992 | 267 | 0.280 |
Why?
|
| Muscle Proteins | 12 | 2002 | 1160 | 0.280 |
Why?
|
| Vitamin B 12 | 1 | 2010 | 529 | 0.280 |
Why?
|
| Basal Metabolism | 5 | 1999 | 163 | 0.280 |
Why?
|
| Chemistry, Physical | 6 | 2006 | 153 | 0.280 |
Why?
|
| Respiratory Insufficiency | 6 | 2011 | 1240 | 0.270 |
Why?
|
| Microwaves | 1 | 2008 | 184 | 0.270 |
Why?
|
| Chemical Phenomena | 6 | 2006 | 486 | 0.270 |
Why?
|
| Analysis of Variance | 12 | 2010 | 6215 | 0.260 |
Why?
|
| Vitamins | 5 | 2003 | 1639 | 0.260 |
Why?
|
| Alkalosis | 3 | 1998 | 55 | 0.260 |
Why?
|
| Eating | 10 | 2013 | 1541 | 0.260 |
Why?
|
| Overweight | 2 | 2019 | 2448 | 0.260 |
Why?
|
| Adipose Tissue | 8 | 2014 | 3324 | 0.260 |
Why?
|
| Muscle Weakness | 1 | 2008 | 412 | 0.250 |
Why?
|
| Iron | 10 | 2003 | 1811 | 0.250 |
Why?
|
| Aspartate Aminotransferases | 6 | 2010 | 415 | 0.250 |
Why?
|
| Linolenic Acids | 3 | 2003 | 7 | 0.250 |
Why?
|
| Iron-Dextran Complex | 3 | 2000 | 14 | 0.250 |
Why?
|
| Shock, Septic | 5 | 1999 | 772 | 0.240 |
Why?
|
| Beverages | 1 | 2010 | 819 | 0.240 |
Why?
|
| Female | 143 | 2022 | 396660 | 0.230 |
Why?
|
| Program Development | 1 | 2010 | 1298 | 0.230 |
Why?
|
| Vitamin K | 2 | 2003 | 314 | 0.220 |
Why?
|
| Lung | 9 | 2006 | 10076 | 0.220 |
Why?
|
| Plaque, Atherosclerotic | 3 | 2021 | 1549 | 0.220 |
Why?
|
| Osmolar Concentration | 6 | 2009 | 654 | 0.220 |
Why?
|
| Hospitalization | 12 | 2015 | 10815 | 0.220 |
Why?
|
| Gastrointestinal Neoplasms | 4 | 2003 | 957 | 0.210 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2024 | 273 | 0.210 |
Why?
|
| Kupffer Cells | 4 | 1998 | 143 | 0.210 |
Why?
|
| Psoas Muscles | 1 | 2023 | 66 | 0.210 |
Why?
|
| Infusions, Intravenous | 15 | 2008 | 2227 | 0.210 |
Why?
|
| Anthropometry | 12 | 1999 | 1345 | 0.210 |
Why?
|
| Renal Dialysis | 4 | 2003 | 1790 | 0.200 |
Why?
|
| Malondialdehyde | 3 | 2009 | 113 | 0.200 |
Why?
|
| Fatty Liver | 6 | 2013 | 811 | 0.200 |
Why?
|
| Health Expenditures | 1 | 2015 | 2390 | 0.200 |
Why?
|
| Leptin | 3 | 2013 | 1599 | 0.190 |
Why?
|
| Acute-Phase Proteins | 3 | 1999 | 251 | 0.190 |
Why?
|
| Selenium | 3 | 2003 | 418 | 0.190 |
Why?
|
| Colon | 4 | 1998 | 1797 | 0.190 |
Why?
|
| Adult | 124 | 2022 | 223317 | 0.190 |
Why?
|
| Trans-Activators | 5 | 2004 | 2856 | 0.190 |
Why?
|
| Toxemia | 3 | 1996 | 14 | 0.190 |
Why?
|
| Intestines | 2 | 2004 | 1905 | 0.180 |
Why?
|
| Recombinant Proteins | 11 | 2004 | 6507 | 0.180 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2002 | 166 | 0.180 |
Why?
|
| Cholecystokinin | 1 | 2001 | 114 | 0.180 |
Why?
|
| Disease Susceptibility | 1 | 2007 | 1791 | 0.180 |
Why?
|
| Cardiopulmonary Bypass | 2 | 1998 | 1097 | 0.180 |
Why?
|
| Diet, Reducing | 13 | 1986 | 487 | 0.180 |
Why?
|
| Clinical Trials as Topic | 3 | 2016 | 8048 | 0.180 |
Why?
|
| Food Handling | 1 | 2001 | 158 | 0.180 |
Why?
|
| Education, Medical | 6 | 2014 | 1746 | 0.180 |
Why?
|
| Adenine Nucleotides | 2 | 1991 | 110 | 0.180 |
Why?
|
| Caseins | 4 | 1998 | 105 | 0.180 |
Why?
|
| Parenteral Nutrition, Home | 1 | 2000 | 39 | 0.170 |
Why?
|
| Body Mass Index | 5 | 2014 | 13048 | 0.170 |
Why?
|
| Kinetics | 28 | 1996 | 6287 | 0.170 |
Why?
|
| Propranolol | 1 | 2002 | 493 | 0.170 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2021 | 3249 | 0.170 |
Why?
|
| Pharmacopoeias as Topic | 2 | 2010 | 16 | 0.170 |
Why?
|
| Gastric Bypass | 1 | 2008 | 820 | 0.170 |
Why?
|
| Prostaglandins | 1 | 2021 | 398 | 0.170 |
Why?
|
| Butter | 1 | 1999 | 22 | 0.170 |
Why?
|
| Leukotriene B4 | 1 | 2021 | 281 | 0.170 |
Why?
|
| Protein Biosynthesis | 17 | 1992 | 2093 | 0.170 |
Why?
|
| Organ Preservation Solutions | 2 | 1991 | 105 | 0.170 |
Why?
|
| Hospital Mortality | 1 | 2014 | 5345 | 0.170 |
Why?
|
| Oleic Acid | 2 | 2015 | 90 | 0.170 |
Why?
|
| Kwashiorkor | 6 | 1996 | 24 | 0.170 |
Why?
|
| Gastric Emptying | 1 | 2002 | 247 | 0.170 |
Why?
|
| Acute Disease | 7 | 2017 | 7236 | 0.170 |
Why?
|
| Brain Injuries | 1 | 2011 | 2053 | 0.170 |
Why?
|
| Cyclosporins | 2 | 1989 | 216 | 0.160 |
Why?
|
| Middle Aged | 100 | 2022 | 223233 | 0.160 |
Why?
|
| Hospitals | 3 | 2009 | 3883 | 0.160 |
Why?
|
| Guinea Pigs | 13 | 2005 | 1309 | 0.160 |
Why?
|
| Acidosis, Lactic | 2 | 1991 | 144 | 0.160 |
Why?
|
| Ascorbic Acid Deficiency | 1 | 1999 | 26 | 0.160 |
Why?
|
| Growth | 3 | 2012 | 366 | 0.160 |
Why?
|
| Trace Elements | 2 | 1999 | 193 | 0.160 |
Why?
|
| Furosemide | 2 | 1989 | 174 | 0.160 |
Why?
|
| Drug Storage | 3 | 2009 | 52 | 0.160 |
Why?
|
| Cognition Disorders | 1 | 2013 | 3968 | 0.160 |
Why?
|
| Postoperative Complications | 18 | 2008 | 15824 | 0.150 |
Why?
|
| Hemofiltration | 1 | 1999 | 58 | 0.150 |
Why?
|
| Diabetes Mellitus | 8 | 1998 | 5886 | 0.150 |
Why?
|
| Hydrochloric Acid | 1 | 1998 | 76 | 0.150 |
Why?
|
| HIV Wasting Syndrome | 1 | 1998 | 99 | 0.150 |
Why?
|
| HIV Infections | 8 | 2009 | 17542 | 0.150 |
Why?
|
| Vitamin E | 1 | 2002 | 872 | 0.150 |
Why?
|
| Oxygen Consumption | 16 | 1992 | 1873 | 0.150 |
Why?
|
| Neoplasm Proteins | 5 | 1994 | 3599 | 0.150 |
Why?
|
| Bacterial Infections | 6 | 1999 | 1390 | 0.150 |
Why?
|
| Lactates | 9 | 1992 | 398 | 0.150 |
Why?
|
| Absorption | 5 | 2003 | 243 | 0.150 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 3 | 2015 | 64 | 0.150 |
Why?
|
| Arrhythmias, Cardiac | 4 | 1992 | 2257 | 0.150 |
Why?
|
| Time Factors | 33 | 2010 | 40154 | 0.150 |
Why?
|
| Aged | 71 | 2022 | 171319 | 0.150 |
Why?
|
| Milk Proteins | 3 | 2008 | 161 | 0.140 |
Why?
|
| Glycemic Index | 2 | 2011 | 400 | 0.140 |
Why?
|
| Opportunistic Infections | 1 | 2000 | 375 | 0.140 |
Why?
|
| Treatment Outcome | 17 | 2018 | 65295 | 0.140 |
Why?
|
| HT29 Cells | 1 | 1997 | 187 | 0.140 |
Why?
|
| Body Composition | 10 | 2009 | 2454 | 0.140 |
Why?
|
| Reference Values | 8 | 2010 | 4918 | 0.140 |
Why?
|
| Organ Preservation | 3 | 1991 | 400 | 0.140 |
Why?
|
| Glucans | 4 | 1999 | 71 | 0.140 |
Why?
|
| Fatty Acids, Omega-6 | 3 | 2006 | 225 | 0.140 |
Why?
|
| Liver Cirrhosis | 1 | 2007 | 1959 | 0.140 |
Why?
|
| Urea | 5 | 1992 | 448 | 0.140 |
Why?
|
| Adenosine Triphosphate | 3 | 1996 | 2001 | 0.140 |
Why?
|
| Fructose-Bisphosphate Aldolase | 1 | 1996 | 43 | 0.140 |
Why?
|
| Gastrointestinal Diseases | 4 | 2014 | 1205 | 0.140 |
Why?
|
| Delivery of Health Care | 1 | 2015 | 5363 | 0.140 |
Why?
|
| Cell Membrane | 2 | 2023 | 3642 | 0.140 |
Why?
|
| Coronary Artery Disease | 4 | 2019 | 6573 | 0.130 |
Why?
|
| Medicare | 2 | 2015 | 6813 | 0.130 |
Why?
|
| Corticosterone | 2 | 2009 | 301 | 0.130 |
Why?
|
| United States Food and Drug Administration | 2 | 2014 | 1672 | 0.130 |
Why?
|
| Intestinal Diseases | 2 | 2000 | 505 | 0.130 |
Why?
|
| Erythropoietin | 1 | 2000 | 718 | 0.130 |
Why?
|
| Arm | 5 | 1994 | 591 | 0.130 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2002 | 1243 | 0.130 |
Why?
|
| Calorimetry, Indirect | 6 | 1999 | 177 | 0.130 |
Why?
|
| Models, Animal | 3 | 2009 | 2121 | 0.130 |
Why?
|
| Neprilysin | 1 | 1999 | 487 | 0.130 |
Why?
|
| Cholestasis | 2 | 2011 | 385 | 0.130 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2010 | 4054 | 0.130 |
Why?
|
| Carbohydrates | 2 | 1996 | 387 | 0.130 |
Why?
|
| Filtration | 1 | 1996 | 227 | 0.130 |
Why?
|
| Obesity, Morbid | 3 | 2004 | 1293 | 0.130 |
Why?
|
| Thinness | 1 | 1999 | 482 | 0.130 |
Why?
|
| Glutathione | 4 | 2003 | 589 | 0.130 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2002 | 2428 | 0.120 |
Why?
|
| Glucose Clamp Technique | 3 | 2003 | 262 | 0.120 |
Why?
|
| Rhabdomyolysis | 1 | 1996 | 150 | 0.120 |
Why?
|
| Yellow Fever | 3 | 1981 | 54 | 0.120 |
Why?
|
| Cognition | 1 | 2013 | 7059 | 0.120 |
Why?
|
| Work of Breathing | 3 | 1992 | 57 | 0.120 |
Why?
|
| Hypertonic Solutions | 2 | 1997 | 82 | 0.120 |
Why?
|
| Food-Drug Interactions | 1 | 2014 | 26 | 0.120 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2000 | 584 | 0.120 |
Why?
|
| Intraoperative Care | 1 | 1999 | 768 | 0.120 |
Why?
|
| Escherichia coli | 6 | 2019 | 4209 | 0.120 |
Why?
|
| Aging | 4 | 2013 | 8729 | 0.120 |
Why?
|
| STAT3 Transcription Factor | 3 | 2004 | 872 | 0.120 |
Why?
|
| Lymph | 3 | 2008 | 78 | 0.120 |
Why?
|
| Bilirubin | 5 | 2011 | 440 | 0.120 |
Why?
|
| Body Temperature Regulation | 3 | 1993 | 292 | 0.120 |
Why?
|
| Orosomucoid | 2 | 2004 | 45 | 0.110 |
Why?
|
| Platelet Aggregation | 2 | 1994 | 769 | 0.110 |
Why?
|
| Mucins | 1 | 1997 | 569 | 0.110 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 1995 | 284 | 0.110 |
Why?
|
| Receptors, Interleukin-1 | 1 | 1995 | 260 | 0.110 |
Why?
|
| Starvation | 11 | 1986 | 141 | 0.110 |
Why?
|
| Tissue Fixation | 1 | 1995 | 245 | 0.110 |
Why?
|
| Carbon Radioisotopes | 12 | 1991 | 544 | 0.110 |
Why?
|
| DNA-Binding Proteins | 5 | 2004 | 9612 | 0.110 |
Why?
|
| Calcium Phosphates | 1 | 1994 | 172 | 0.110 |
Why?
|
| Growth Hormone | 2 | 1996 | 572 | 0.110 |
Why?
|
| Micronutrients | 2 | 2014 | 390 | 0.110 |
Why?
|
| Cimetidine | 2 | 1990 | 76 | 0.110 |
Why?
|
| Guideline Adherence | 2 | 2017 | 2232 | 0.110 |
Why?
|
| Body Water | 2 | 1993 | 337 | 0.110 |
Why?
|
| Signal Transduction | 6 | 2004 | 23621 | 0.110 |
Why?
|
| Cell Division | 6 | 2002 | 4473 | 0.110 |
Why?
|
| Peritoneal Dialysis | 3 | 1990 | 161 | 0.100 |
Why?
|
| Anti-HIV Agents | 1 | 2009 | 4567 | 0.100 |
Why?
|
| Transferrin | 10 | 1996 | 283 | 0.100 |
Why?
|
| Nutrition Therapy | 1 | 2014 | 101 | 0.100 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 1994 | 496 | 0.100 |
Why?
|
| Disease Models, Animal | 11 | 2014 | 18330 | 0.100 |
Why?
|
| Hydrogen-Ion Concentration | 6 | 2010 | 2478 | 0.100 |
Why?
|
| Adenosine | 3 | 1993 | 812 | 0.100 |
Why?
|
| Splanchnic Circulation | 2 | 1992 | 122 | 0.100 |
Why?
|
| Hypersensitivity, Delayed | 9 | 1985 | 491 | 0.100 |
Why?
|
| STAT1 Transcription Factor | 2 | 2004 | 341 | 0.100 |
Why?
|
| Crohn Disease | 5 | 2000 | 2295 | 0.100 |
Why?
|
| United States | 15 | 2017 | 72971 | 0.100 |
Why?
|
| Cold Temperature | 2 | 1993 | 793 | 0.090 |
Why?
|
| Inflammation Mediators | 3 | 2010 | 1889 | 0.090 |
Why?
|
| Infant, Newborn | 14 | 2013 | 26396 | 0.090 |
Why?
|
| Sarcoma, Experimental | 1 | 1991 | 116 | 0.090 |
Why?
|
| Infant, Premature | 3 | 2011 | 2125 | 0.090 |
Why?
|
| Alzheimer Disease | 1 | 2013 | 8717 | 0.090 |
Why?
|
| Lipid Peroxidation | 3 | 2013 | 276 | 0.090 |
Why?
|
| Hemorrhage | 2 | 2002 | 3464 | 0.090 |
Why?
|
| Linoleic Acids | 3 | 2002 | 39 | 0.090 |
Why?
|
| Tyrosine | 9 | 1989 | 1425 | 0.090 |
Why?
|
| Preoperative Care | 7 | 1995 | 2252 | 0.090 |
Why?
|
| Carnitine | 2 | 1989 | 253 | 0.090 |
Why?
|
| Drug Compounding | 4 | 2006 | 236 | 0.090 |
Why?
|
| Prospective Studies | 21 | 2022 | 54886 | 0.090 |
Why?
|
| Calcium | 4 | 2009 | 5792 | 0.090 |
Why?
|
| Vitamin B Deficiency | 1 | 2010 | 12 | 0.090 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1997 | 1854 | 0.090 |
Why?
|
| Inpatients | 1 | 2002 | 2563 | 0.090 |
Why?
|
| Epidermis | 1 | 1993 | 539 | 0.090 |
Why?
|
| Aluminum Hydroxide | 1 | 1990 | 55 | 0.090 |
Why?
|
| Nucleotides | 1 | 1993 | 454 | 0.090 |
Why?
|
| Chemical Precipitation | 4 | 2009 | 174 | 0.090 |
Why?
|
| Fatty Acids, Volatile | 1 | 1991 | 100 | 0.090 |
Why?
|
| Mutation | 1 | 2015 | 30211 | 0.090 |
Why?
|
| Leukocytes | 4 | 1995 | 2034 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 6 | 2010 | 10393 | 0.090 |
Why?
|
| History, 20th Century | 4 | 2017 | 2765 | 0.090 |
Why?
|
| Famotidine | 1 | 1989 | 17 | 0.080 |
Why?
|
| Chyle | 1 | 1989 | 17 | 0.080 |
Why?
|
| Temperature | 3 | 2010 | 2232 | 0.080 |
Why?
|
| Ghrelin | 2 | 2009 | 251 | 0.080 |
Why?
|
| Jejunum | 3 | 2002 | 474 | 0.080 |
Why?
|
| Aged, 80 and over | 17 | 2017 | 59548 | 0.080 |
Why?
|
| Creatine | 1 | 2011 | 424 | 0.080 |
Why?
|
| Physical Exertion | 3 | 1990 | 667 | 0.080 |
Why?
|
| Xylitol | 4 | 1991 | 23 | 0.080 |
Why?
|
| Surgical Procedures, Operative | 6 | 2003 | 1931 | 0.080 |
Why?
|
| Pancreatitis | 4 | 1993 | 1087 | 0.080 |
Why?
|
| Porphyrias | 1 | 2008 | 57 | 0.080 |
Why?
|
| Chylothorax | 1 | 1989 | 83 | 0.080 |
Why?
|
| Kidney Diseases | 3 | 1989 | 2099 | 0.080 |
Why?
|
| Cholesterol, HDL | 2 | 2009 | 1816 | 0.080 |
Why?
|
| Body Temperature | 4 | 1996 | 780 | 0.080 |
Why?
|
| Ribonucleotides | 1 | 1989 | 114 | 0.080 |
Why?
|
| Dioxins | 1 | 2009 | 91 | 0.080 |
Why?
|
| Cell Cycle | 5 | 1995 | 2927 | 0.080 |
Why?
|
| Skin Tests | 5 | 1985 | 630 | 0.080 |
Why?
|
| History, 21st Century | 2 | 2017 | 1574 | 0.080 |
Why?
|
| Growth Disorders | 1 | 1993 | 635 | 0.080 |
Why?
|
| Tissue Preservation | 1 | 1989 | 170 | 0.080 |
Why?
|
| Peptide Hydrolases | 1 | 1991 | 610 | 0.080 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2008 | 143 | 0.080 |
Why?
|
| Conservation of Natural Resources | 1 | 2010 | 209 | 0.080 |
Why?
|
| Causality | 2 | 2010 | 1253 | 0.080 |
Why?
|
| Nutrition Policy | 2 | 2010 | 467 | 0.080 |
Why?
|
| Methylmercury Compounds | 1 | 2009 | 103 | 0.080 |
Why?
|
| Flavonoids | 1 | 2011 | 447 | 0.070 |
Why?
|
| Phenytoin | 1 | 1988 | 189 | 0.070 |
Why?
|
| Drug Interactions | 2 | 2003 | 1419 | 0.070 |
Why?
|
| Lipogenesis | 1 | 2010 | 217 | 0.070 |
Why?
|
| Arginine | 1 | 1992 | 931 | 0.070 |
Why?
|
| Abdominal Neoplasms | 2 | 1989 | 286 | 0.070 |
Why?
|
| Exercise | 2 | 2018 | 5954 | 0.070 |
Why?
|
| Lipodystrophy | 1 | 2009 | 145 | 0.070 |
Why?
|
| Fluid Therapy | 3 | 1991 | 587 | 0.070 |
Why?
|
| Metabolism | 1 | 1989 | 193 | 0.070 |
Why?
|
| Insulin Resistance | 5 | 2009 | 3986 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2007 | 588 | 0.070 |
Why?
|
| Tissue Donors | 2 | 1995 | 2387 | 0.070 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2009 | 235 | 0.070 |
Why?
|
| Double-Blind Method | 7 | 2008 | 12451 | 0.070 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1988 | 189 | 0.070 |
Why?
|
| Progesterone | 1 | 2011 | 752 | 0.070 |
Why?
|
| Infant Nutritional Physiological Phenomena | 2 | 2008 | 352 | 0.070 |
Why?
|
| Oxidation-Reduction | 11 | 1997 | 2221 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 5 | 1995 | 1531 | 0.070 |
Why?
|
| Glutathione Transferase | 1 | 2009 | 565 | 0.070 |
Why?
|
| Dietetics | 3 | 2014 | 34 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2017 | 10748 | 0.070 |
Why?
|
| Injections, Intraperitoneal | 3 | 1997 | 411 | 0.070 |
Why?
|
| Lipopolysaccharides | 3 | 2019 | 2217 | 0.070 |
Why?
|
| Pharmaceutical Preparations | 2 | 1994 | 1085 | 0.070 |
Why?
|
| Neoplasms | 8 | 2024 | 22350 | 0.070 |
Why?
|
| Flow Cytometry | 6 | 1999 | 5891 | 0.070 |
Why?
|
| Societies, Medical | 4 | 2014 | 3964 | 0.070 |
Why?
|
| Tritium | 5 | 1995 | 707 | 0.070 |
Why?
|
| RNA, Messenger | 4 | 1999 | 12793 | 0.070 |
Why?
|
| Neoplasm Transplantation | 5 | 1994 | 2012 | 0.070 |
Why?
|
| Immunity, Cellular | 7 | 1985 | 1560 | 0.070 |
Why?
|
| Ecosystem | 1 | 2010 | 489 | 0.070 |
Why?
|
| Lactic Acid | 6 | 1992 | 1139 | 0.070 |
Why?
|
| Coronary Vessels | 1 | 2017 | 3114 | 0.070 |
Why?
|
| Kidney | 2 | 1994 | 7063 | 0.070 |
Why?
|
| Keto Acids | 1 | 1986 | 34 | 0.070 |
Why?
|
| Quality Control | 1 | 2009 | 835 | 0.070 |
Why?
|
| Europe | 2 | 2012 | 3432 | 0.060 |
Why?
|
| Metabolome | 1 | 2013 | 1008 | 0.060 |
Why?
|
| Brain | 1 | 2013 | 27163 | 0.060 |
Why?
|
| Evaluation Studies as Topic | 7 | 1993 | 1623 | 0.060 |
Why?
|
| Ferritins | 2 | 2000 | 601 | 0.060 |
Why?
|
| Wound Infection | 2 | 1979 | 244 | 0.060 |
Why?
|
| Glycolysis | 1 | 1989 | 836 | 0.060 |
Why?
|
| Risk Factors | 11 | 2021 | 74886 | 0.060 |
Why?
|
| Alcoholism | 2 | 1996 | 1980 | 0.060 |
Why?
|
| Area Under Curve | 1 | 2009 | 1639 | 0.060 |
Why?
|
| Cholesterol | 4 | 1999 | 2905 | 0.060 |
Why?
|
| Portal Vein | 1 | 2008 | 437 | 0.060 |
Why?
|
| Dietary Fiber | 2 | 1999 | 767 | 0.060 |
Why?
|
| PPAR alpha | 1 | 2006 | 177 | 0.060 |
Why?
|
| Immune Tolerance | 1 | 1994 | 2322 | 0.060 |
Why?
|
| Zinc | 5 | 1995 | 675 | 0.060 |
Why?
|
| Thrombophlebitis | 3 | 1996 | 289 | 0.060 |
Why?
|
| Respiration | 6 | 1995 | 1655 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2270 | 0.060 |
Why?
|
| Homeostasis | 2 | 2010 | 3345 | 0.060 |
Why?
|
| Metabolic Clearance Rate | 4 | 1994 | 361 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2003 | 9410 | 0.060 |
Why?
|
| Fever | 8 | 1989 | 1605 | 0.060 |
Why?
|
| Bromodeoxyuridine | 3 | 1995 | 310 | 0.060 |
Why?
|
| Mice | 13 | 2019 | 81912 | 0.060 |
Why?
|
| Ischemia | 1 | 1993 | 1905 | 0.060 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 1999 | 2441 | 0.060 |
Why?
|
| Hypercholesterolemia | 3 | 1999 | 1144 | 0.060 |
Why?
|
| Health Education | 1 | 2010 | 1058 | 0.060 |
Why?
|
| Precipitin Tests | 1 | 2004 | 816 | 0.060 |
Why?
|
| Communicable Diseases | 1 | 1992 | 872 | 0.060 |
Why?
|
| beta-Glucans | 2 | 1994 | 129 | 0.050 |
Why?
|
| Corn Oil | 2 | 2021 | 29 | 0.050 |
Why?
|
| Blood Sedimentation | 2 | 2000 | 235 | 0.050 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1986 | 727 | 0.050 |
Why?
|
| Diabetic Nephropathies | 3 | 1989 | 974 | 0.050 |
Why?
|
| Metabolomics | 1 | 2013 | 1675 | 0.050 |
Why?
|
| Life Style | 2 | 2014 | 3931 | 0.050 |
Why?
|
| Hydroxamic Acids | 1 | 2006 | 483 | 0.050 |
Why?
|
| Infant Formula | 1 | 2005 | 193 | 0.050 |
Why?
|
| Methylhistidines | 4 | 1996 | 35 | 0.050 |
Why?
|
| Luteinizing Hormone | 1 | 1986 | 822 | 0.050 |
Why?
|
| Prostatic Neoplasms | 2 | 2003 | 11097 | 0.050 |
Why?
|
| Organ Size | 6 | 1991 | 2264 | 0.050 |
Why?
|
| Hemodynamics | 4 | 1992 | 4186 | 0.050 |
Why?
|
| Phagocytosis | 3 | 1999 | 1526 | 0.050 |
Why?
|
| Enteritis | 2 | 2001 | 164 | 0.050 |
Why?
|
| Adenocarcinoma | 3 | 1991 | 6360 | 0.050 |
Why?
|
| Fatigue | 1 | 2010 | 1556 | 0.050 |
Why?
|
| Macrophages | 2 | 1996 | 5785 | 0.050 |
Why?
|
| Liver Glycogen | 4 | 1991 | 36 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 8 | 2019 | 22361 | 0.050 |
Why?
|
| Chronic Disease | 4 | 2011 | 9362 | 0.050 |
Why?
|
| Subclavian Vein | 2 | 1986 | 57 | 0.050 |
Why?
|
| Drug Incompatibility | 3 | 2005 | 11 | 0.050 |
Why?
|
| Glycogen | 2 | 2002 | 252 | 0.050 |
Why?
|
| Digestive System | 1 | 2003 | 244 | 0.050 |
Why?
|
| Skinfold Thickness | 6 | 1986 | 164 | 0.050 |
Why?
|
| Thromboxane B2 | 3 | 1997 | 143 | 0.050 |
Why?
|
| Pylorus | 1 | 2002 | 86 | 0.050 |
Why?
|
| Abdominal Pain | 1 | 2008 | 1069 | 0.050 |
Why?
|
| Prognosis | 6 | 2010 | 29963 | 0.050 |
Why?
|
| Health Promotion | 1 | 2014 | 2210 | 0.050 |
Why?
|
| Agriculture | 1 | 2003 | 186 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2003 | 474 | 0.050 |
Why?
|
| Lung Diseases | 2 | 2011 | 1942 | 0.050 |
Why?
|
| Fellowships and Scholarships | 1 | 2010 | 1135 | 0.050 |
Why?
|
| Peptide Hormones | 1 | 2002 | 132 | 0.050 |
Why?
|
| Janus Kinase 1 | 1 | 2002 | 108 | 0.050 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2002 | 220 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2003 | 478 | 0.050 |
Why?
|
| Injections, Intravenous | 4 | 1995 | 1377 | 0.050 |
Why?
|
| Diabetes Complications | 3 | 1998 | 1319 | 0.050 |
Why?
|
| Data Collection | 1 | 2010 | 3321 | 0.050 |
Why?
|
| Hydroxyproline | 2 | 1996 | 109 | 0.050 |
Why?
|
| Biotechnology | 1 | 2003 | 282 | 0.050 |
Why?
|
| Immunoblotting | 1 | 2004 | 1647 | 0.050 |
Why?
|
| Catheterization | 3 | 1988 | 1430 | 0.050 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2008 | 862 | 0.050 |
Why?
|
| Pharmaceutical Vehicles | 2 | 1991 | 56 | 0.050 |
Why?
|
| Excipients | 1 | 2001 | 96 | 0.050 |
Why?
|
| Blood Cell Count | 2 | 2018 | 404 | 0.050 |
Why?
|
| Fetal Growth Retardation | 1 | 2005 | 592 | 0.050 |
Why?
|
| Raffinose | 2 | 1991 | 57 | 0.040 |
Why?
|
| Arachidonic Acids | 2 | 1999 | 296 | 0.040 |
Why?
|
| Iron-Binding Proteins | 1 | 2000 | 83 | 0.040 |
Why?
|
| Drug Combinations | 3 | 2003 | 2086 | 0.040 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2002 | 224 | 0.040 |
Why?
|
| Milk, Human | 1 | 2005 | 490 | 0.040 |
Why?
|
| Blood Urea Nitrogen | 2 | 1992 | 189 | 0.040 |
Why?
|
| Carbon Dioxide | 6 | 1991 | 1137 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2009 | 22254 | 0.040 |
Why?
|
| Health Personnel | 1 | 2014 | 3387 | 0.040 |
Why?
|
| Sorbitol | 1 | 2000 | 61 | 0.040 |
Why?
|
| Rabbits | 4 | 1997 | 4751 | 0.040 |
Why?
|
| Monitoring, Physiologic | 5 | 1992 | 1794 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2003 | 694 | 0.040 |
Why?
|
| Esterification | 1 | 1999 | 39 | 0.040 |
Why?
|
| Oxygen | 2 | 1990 | 4252 | 0.040 |
Why?
|
| Phosphoproteins | 2 | 2001 | 2448 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2023 | 20741 | 0.040 |
Why?
|
| Prostaglandins E | 1 | 1999 | 166 | 0.040 |
Why?
|
| Phenylalanine | 3 | 1987 | 367 | 0.040 |
Why?
|
| Jugular Veins | 1 | 1981 | 211 | 0.040 |
Why?
|
| Receptors, Somatotropin | 1 | 1999 | 58 | 0.040 |
Why?
|
| Physicians | 3 | 2014 | 4593 | 0.040 |
Why?
|
| Portacaval Shunt, Surgical | 3 | 1989 | 46 | 0.040 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2000 | 190 | 0.040 |
Why?
|
| Cardiovascular Diseases | 3 | 2021 | 15645 | 0.040 |
Why?
|
| Indomethacin | 2 | 1991 | 323 | 0.040 |
Why?
|
| Phosphotyrosine | 2 | 1999 | 458 | 0.040 |
Why?
|
| Mitochondria | 1 | 2013 | 3678 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 12986 | 0.040 |
Why?
|
| Feeding Behavior | 1 | 2011 | 3207 | 0.040 |
Why?
|
| Respiratory Muscles | 2 | 1990 | 144 | 0.040 |
Why?
|
| Long-Term Care | 2 | 2002 | 631 | 0.040 |
Why?
|
| Allopurinol | 2 | 1991 | 202 | 0.040 |
Why?
|
| Ileum | 2 | 1998 | 558 | 0.040 |
Why?
|
| Intestinal Mucosa | 3 | 1996 | 3043 | 0.040 |
Why?
|
| Hormones | 2 | 1995 | 865 | 0.040 |
Why?
|
| Receptor, IGF Type 1 | 2 | 1998 | 384 | 0.040 |
Why?
|
| Phosphorylation | 4 | 2003 | 8310 | 0.040 |
Why?
|
| Morpholines | 1 | 2002 | 584 | 0.040 |
Why?
|
| Endocrine Glands | 1 | 1998 | 101 | 0.040 |
Why?
|
| Biological Products | 1 | 1988 | 948 | 0.040 |
Why?
|
| Glucagon | 3 | 1990 | 534 | 0.040 |
Why?
|
| Superoxides | 1 | 1999 | 388 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 4 | 1 | 1998 | 24 | 0.040 |
Why?
|
| Endothelium | 2 | 1998 | 768 | 0.040 |
Why?
|
| Neutrophil Activation | 1 | 1999 | 180 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2011 | 41718 | 0.040 |
Why?
|
| Injury Severity Score | 1 | 2022 | 1049 | 0.040 |
Why?
|
| Microspheres | 1 | 2001 | 774 | 0.040 |
Why?
|
| Alanine | 5 | 1988 | 613 | 0.040 |
Why?
|
| Acute Kidney Injury | 2 | 1990 | 1946 | 0.040 |
Why?
|
| Prostaglandins F | 1 | 1997 | 79 | 0.040 |
Why?
|
| Hematocrit | 2 | 1996 | 622 | 0.040 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 1 | 1997 | 80 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 1995 | 9245 | 0.040 |
Why?
|
| Glycerol | 3 | 1988 | 274 | 0.040 |
Why?
|
| Hematinics | 1 | 2000 | 282 | 0.040 |
Why?
|
| Deoxyglucose | 2 | 1995 | 322 | 0.040 |
Why?
|
| Hydroxybutyrates | 4 | 1987 | 76 | 0.040 |
Why?
|
| Calcitonin | 1 | 1999 | 328 | 0.040 |
Why?
|
| Vitamin D | 1 | 2011 | 3312 | 0.040 |
Why?
|
| Anorexia | 1 | 1998 | 153 | 0.040 |
Why?
|
| Regional Blood Flow | 2 | 1991 | 1479 | 0.040 |
Why?
|
| Reference Standards | 1 | 2001 | 1011 | 0.040 |
Why?
|
| APACHE | 1 | 1998 | 268 | 0.040 |
Why?
|
| Dinoprostone | 2 | 1997 | 597 | 0.040 |
Why?
|
| Child | 15 | 2013 | 80771 | 0.040 |
Why?
|
| Severity of Illness Index | 5 | 2001 | 15925 | 0.030 |
Why?
|
| Apolipoproteins A | 2 | 1987 | 95 | 0.030 |
Why?
|
| Premedication | 2 | 1994 | 245 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2010 | 8732 | 0.030 |
Why?
|
| Hematologic Diseases | 1 | 1981 | 498 | 0.030 |
Why?
|
| Infant | 6 | 2011 | 36485 | 0.030 |
Why?
|
| Respiratory Burst | 1 | 1997 | 110 | 0.030 |
Why?
|
| Warfarin | 3 | 1996 | 1493 | 0.030 |
Why?
|
| Lasers | 1 | 2001 | 951 | 0.030 |
Why?
|
| Depression | 2 | 2014 | 8234 | 0.030 |
Why?
|
| Administration, Oral | 2 | 2017 | 4026 | 0.030 |
Why?
|
| Reticulocyte Count | 1 | 1996 | 36 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 1 | 1996 | 69 | 0.030 |
Why?
|
| Ubiquitins | 1 | 1998 | 365 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1997 | 411 | 0.030 |
Why?
|
| General Surgery | 1 | 1988 | 1720 | 0.030 |
Why?
|
| Leukocyte Count | 8 | 1986 | 1606 | 0.030 |
Why?
|
| Prader-Willi Syndrome | 1 | 1977 | 80 | 0.030 |
Why?
|
| Chromatography, Thin Layer | 1 | 1996 | 211 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 1998 | 416 | 0.030 |
Why?
|
| Macrophages, Peritoneal | 1 | 1997 | 244 | 0.030 |
Why?
|
| Scurvy | 1 | 1996 | 36 | 0.030 |
Why?
|
| Rats, Inbred F344 | 3 | 1994 | 820 | 0.030 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 1996 | 2204 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2002 | 3587 | 0.030 |
Why?
|
| Helianthus | 1 | 1995 | 10 | 0.030 |
Why?
|
| Plant Extracts | 1 | 1999 | 496 | 0.030 |
Why?
|
| Epithelioid Cells | 1 | 1996 | 60 | 0.030 |
Why?
|
| Stomach | 4 | 1989 | 701 | 0.030 |
Why?
|
| Infection Control | 1 | 2003 | 984 | 0.030 |
Why?
|
| Transplantation, Homologous | 3 | 1995 | 4838 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 2 | 1999 | 4522 | 0.030 |
Why?
|
| Albumins | 2 | 1990 | 577 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2007 | 4560 | 0.030 |
Why?
|
| Dietary Services | 1 | 1995 | 17 | 0.030 |
Why?
|
| Cystic Fibrosis | 1 | 2005 | 1292 | 0.030 |
Why?
|
| Erythrocyte Indices | 1 | 1996 | 143 | 0.030 |
Why?
|
| Digestion | 1 | 1995 | 53 | 0.030 |
Why?
|
| Ascorbic Acid | 1 | 1999 | 658 | 0.030 |
Why?
|
| Choline | 2 | 1988 | 511 | 0.030 |
Why?
|
| Retrospective Studies | 11 | 2023 | 81659 | 0.030 |
Why?
|
| Length of Stay | 3 | 2003 | 6489 | 0.030 |
Why?
|
| Blood Proteins | 7 | 1986 | 1190 | 0.030 |
Why?
|
| Histocytological Preparation Techniques | 1 | 1995 | 31 | 0.030 |
Why?
|
| Light | 1 | 2001 | 1358 | 0.030 |
Why?
|
| Testosterone | 1 | 1986 | 2490 | 0.030 |
Why?
|
| Potassium | 5 | 1990 | 1314 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2000 | 1443 | 0.030 |
Why?
|
| Phytosterols | 1 | 2014 | 55 | 0.030 |
Why?
|
| Protein Precursors | 1 | 1999 | 1134 | 0.030 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 1996 | 301 | 0.030 |
Why?
|
| Genetic Engineering | 1 | 2000 | 935 | 0.030 |
Why?
|
| DNA, Neoplasm | 3 | 1994 | 1741 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 2017 | 640 | 0.030 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2002 | 1126 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 1999 | 1364 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2000 | 963 | 0.030 |
Why?
|
| Gastrostomy | 1 | 1997 | 325 | 0.030 |
Why?
|
| Arthroplasty, Replacement | 1 | 2018 | 311 | 0.030 |
Why?
|
| Statistics as Topic | 3 | 1995 | 2350 | 0.030 |
Why?
|
| Adolescent | 17 | 2022 | 89046 | 0.030 |
Why?
|
| Diagnosis-Related Groups | 1 | 1996 | 445 | 0.030 |
Why?
|
| Radioisotope Dilution Technique | 2 | 1991 | 70 | 0.030 |
Why?
|
| Postoperative Period | 6 | 1990 | 1824 | 0.030 |
Why?
|
| Glucose Solution, Hypertonic | 3 | 1987 | 10 | 0.030 |
Why?
|
| Dental Hygienists | 1 | 2014 | 32 | 0.030 |
Why?
|
| Thromboxanes | 2 | 1991 | 45 | 0.030 |
Why?
|
| Glucose Tolerance Test | 2 | 1995 | 1181 | 0.030 |
Why?
|
| Interleukin-2 | 2 | 1994 | 1894 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2002 | 2144 | 0.030 |
Why?
|
| Mumps | 2 | 1983 | 71 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2014 | 5947 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 1997 | 1587 | 0.030 |
Why?
|
| Adenosine Diphosphate | 1 | 1994 | 421 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 1995 | 551 | 0.030 |
Why?
|
| Acidosis | 3 | 1987 | 271 | 0.030 |
Why?
|
| Palmitic Acids | 3 | 1989 | 53 | 0.030 |
Why?
|
| Societies, Scientific | 1 | 2014 | 223 | 0.030 |
Why?
|
| Hepatitis, Chronic | 1 | 1993 | 53 | 0.030 |
Why?
|
| Liver Function Tests | 4 | 1990 | 526 | 0.030 |
Why?
|
| Formaldehyde | 1 | 1995 | 360 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2006 | 2817 | 0.030 |
Why?
|
| Antithrombin III | 2 | 1983 | 128 | 0.030 |
Why?
|
| Epinephrine | 2 | 1994 | 782 | 0.030 |
Why?
|
| Complement System Proteins | 2 | 1995 | 738 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 1999 | 2105 | 0.030 |
Why?
|
| Mumps virus | 1 | 1972 | 23 | 0.030 |
Why?
|
| Solubility | 1 | 1994 | 1078 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 1981 | 1840 | 0.030 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 1993 | 108 | 0.030 |
Why?
|
| Extracellular Space | 2 | 1993 | 563 | 0.030 |
Why?
|
| Mathematics | 5 | 1994 | 696 | 0.020 |
Why?
|
| Meningoencephalitis | 1 | 1972 | 82 | 0.020 |
Why?
|
| Membrane Lipids | 1 | 2013 | 241 | 0.020 |
Why?
|
| Blood Gas Analysis | 2 | 1990 | 383 | 0.020 |
Why?
|
| Disease | 1 | 1977 | 675 | 0.020 |
Why?
|
| Dehydration | 1 | 1993 | 216 | 0.020 |
Why?
|
| Pseudomonas Infections | 3 | 1986 | 623 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1995 | 1697 | 0.020 |
Why?
|
| Computers | 1 | 1994 | 589 | 0.020 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 1991 | 58 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2002 | 2647 | 0.020 |
Why?
|
| Hypoxanthines | 1 | 1991 | 35 | 0.020 |
Why?
|
| Cholesterol Esters | 2 | 1989 | 68 | 0.020 |
Why?
|
| Blood Component Transfusion | 1 | 1992 | 141 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2001 | 2883 | 0.020 |
Why?
|
| Hypoxanthine | 1 | 1991 | 28 | 0.020 |
Why?
|
| Aminophylline | 1 | 1991 | 41 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 1999 | 1429 | 0.020 |
Why?
|
| Hepatitis | 1 | 1993 | 226 | 0.020 |
Why?
|
| Incidence | 5 | 1999 | 21526 | 0.020 |
Why?
|
| Leukocytosis | 2 | 1982 | 248 | 0.020 |
Why?
|
| Cholangitis, Sclerosing | 1 | 1993 | 179 | 0.020 |
Why?
|
| Models, Educational | 1 | 2014 | 375 | 0.020 |
Why?
|
| Disease Progression | 2 | 2019 | 13646 | 0.020 |
Why?
|
| Phenylacetates | 1 | 1991 | 112 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 1986 | 4268 | 0.020 |
Why?
|
| Models, Biological | 7 | 1994 | 9464 | 0.020 |
Why?
|
| DNA | 3 | 1995 | 7210 | 0.020 |
Why?
|
| Calorimetry | 1 | 1991 | 132 | 0.020 |
Why?
|
| Lipase | 1 | 1993 | 320 | 0.020 |
Why?
|
| Technetium Tc 99m Sulfur Colloid | 1 | 1990 | 63 | 0.020 |
Why?
|
| Nurse Practitioners | 1 | 2014 | 271 | 0.020 |
Why?
|
| Hypoproteinemia | 1 | 1990 | 11 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2006 | 3778 | 0.020 |
Why?
|
| Hepatic Encephalopathy | 2 | 1985 | 143 | 0.020 |
Why?
|
| Femoral Fractures | 3 | 1985 | 376 | 0.020 |
Why?
|
| Forecasting | 2 | 1990 | 2936 | 0.020 |
Why?
|
| Postmenopause | 1 | 1999 | 2518 | 0.020 |
Why?
|
| Retinol-Binding Proteins | 4 | 1983 | 67 | 0.020 |
Why?
|
| Specimen Handling | 1 | 1995 | 706 | 0.020 |
Why?
|
| Calcium Gluconate | 1 | 2009 | 22 | 0.020 |
Why?
|
| Hemoglobins | 1 | 1996 | 1531 | 0.020 |
Why?
|
| Heparin | 2 | 1991 | 1636 | 0.020 |
Why?
|
| Abdomen | 2 | 1994 | 1138 | 0.020 |
Why?
|
| Acid-Base Equilibrium | 1 | 1990 | 180 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 1999 | 2392 | 0.020 |
Why?
|
| Maternal-Fetal Exchange | 2 | 1989 | 454 | 0.020 |
Why?
|
| Up-Regulation | 1 | 1999 | 4143 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 2 | 2002 | 5537 | 0.020 |
Why?
|
| Lipolysis | 2 | 1988 | 211 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2014 | 812 | 0.020 |
Why?
|
| Histamine H2 Antagonists | 1 | 1991 | 169 | 0.020 |
Why?
|
| Hair | 2 | 1987 | 508 | 0.020 |
Why?
|
| Phosphorus | 1 | 1990 | 336 | 0.020 |
Why?
|
| Rest | 1 | 1994 | 941 | 0.020 |
Why?
|
| Follow-Up Studies | 4 | 2017 | 39317 | 0.020 |
Why?
|
| Age Factors | 3 | 2001 | 18401 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 1999 | 2979 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2010 | 24299 | 0.020 |
Why?
|
| Embryonic and Fetal Development | 1 | 1989 | 420 | 0.020 |
Why?
|
| Home Nursing | 3 | 1984 | 92 | 0.020 |
Why?
|
| Heart Valve Diseases | 1 | 1976 | 1029 | 0.020 |
Why?
|
| Intermittent Positive-Pressure Ventilation | 1 | 1988 | 15 | 0.020 |
Why?
|
| Monokines | 1 | 1988 | 71 | 0.020 |
Why?
|
| Hunger | 2 | 2003 | 207 | 0.020 |
Why?
|
| Germ-Free Life | 1 | 1988 | 187 | 0.020 |
Why?
|
| Thoracic Surgery | 1 | 1994 | 727 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1999 | 2678 | 0.020 |
Why?
|
| Cholelithiasis | 1 | 1989 | 408 | 0.020 |
Why?
|
| Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 1987 | 33 | 0.020 |
Why?
|
| Methods | 4 | 1985 | 1065 | 0.020 |
Why?
|
| Positive-Pressure Respiration | 1 | 1992 | 713 | 0.020 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2011 | 418 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 6310 | 0.020 |
Why?
|
| DNA Replication | 1 | 1994 | 1426 | 0.020 |
Why?
|
| Equipment Failure | 1 | 1990 | 585 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2008 | 2586 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 1992 | 1228 | 0.020 |
Why?
|
| STAT5 Transcription Factor | 2 | 1999 | 268 | 0.020 |
Why?
|
| Blood Pressure | 3 | 1992 | 8531 | 0.020 |
Why?
|
| Adenine | 1 | 1993 | 995 | 0.020 |
Why?
|
| Reagent Kits, Diagnostic | 2 | 1986 | 238 | 0.020 |
Why?
|
| Radioisotopes | 1 | 1989 | 509 | 0.020 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1989 | 389 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2001 | 558 | 0.020 |
Why?
|
| Alanine Transaminase | 2 | 2006 | 609 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2002 | 3683 | 0.020 |
Why?
|
| Immunization | 2 | 1981 | 1218 | 0.020 |
Why?
|
| Pregnancy, Animal | 1 | 1987 | 124 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 1999 | 4045 | 0.020 |
Why?
|
| Oligopeptides | 1 | 1992 | 1195 | 0.020 |
Why?
|
| Medicine | 2 | 2010 | 944 | 0.020 |
Why?
|
| Edetic Acid | 1 | 1987 | 277 | 0.020 |
Why?
|
| Mental Disorders | 1 | 2006 | 6873 | 0.020 |
Why?
|
| Leiomyoma | 1 | 1991 | 644 | 0.020 |
Why?
|
| Retinopathy of Prematurity | 1 | 2011 | 450 | 0.020 |
Why?
|
| Perfusion | 1 | 1991 | 1409 | 0.020 |
Why?
|
| Antilymphocyte Serum | 1 | 1988 | 490 | 0.020 |
Why?
|
| Freezing | 1 | 1987 | 310 | 0.020 |
Why?
|
| Catheterization, Peripheral | 1 | 2009 | 346 | 0.020 |
Why?
|
| Graft Rejection | 1 | 1999 | 4498 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2017 | 4525 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 1996 | 2902 | 0.020 |
Why?
|
| Feces | 2 | 1987 | 1508 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 1990 | 1208 | 0.020 |
Why?
|
| Acetoacetates | 1 | 1985 | 18 | 0.020 |
Why?
|
| Intestinal Volvulus | 1 | 2006 | 82 | 0.020 |
Why?
|
| Certification | 1 | 1989 | 420 | 0.020 |
Why?
|
| Protein Binding | 2 | 1996 | 9327 | 0.020 |
Why?
|
| Hyperemesis Gravidarum | 1 | 1985 | 24 | 0.020 |
Why?
|
| Minerals | 2 | 1977 | 279 | 0.020 |
Why?
|
| Glycerides | 1 | 1985 | 67 | 0.020 |
Why?
|
| Vaccination | 1 | 1977 | 3434 | 0.020 |
Why?
|
| Hepatitis, Viral, Human | 1 | 1985 | 141 | 0.010 |
Why?
|
| Janus Kinase 2 | 2 | 1999 | 561 | 0.010 |
Why?
|
| Behavior Therapy | 3 | 1985 | 886 | 0.010 |
Why?
|
| Spleen | 3 | 1986 | 2292 | 0.010 |
Why?
|
| Splenectomy | 1 | 1986 | 390 | 0.010 |
Why?
|
| Bile Acids and Salts | 1 | 1986 | 398 | 0.010 |
Why?
|
| Pyrogens | 1 | 1983 | 17 | 0.010 |
Why?
|
| Neutrophils | 1 | 1997 | 3779 | 0.010 |
Why?
|
| Iatrogenic Disease | 1 | 1987 | 551 | 0.010 |
Why?
|
| Motor Activity | 1 | 2014 | 2713 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2000 | 15424 | 0.010 |
Why?
|
| Peritonitis | 1 | 1986 | 368 | 0.010 |
Why?
|
| Legislation, Food | 1 | 2003 | 17 | 0.010 |
Why?
|
| Exercise Therapy | 1 | 1990 | 939 | 0.010 |
Why?
|
| Thyroxine-Binding Proteins | 1 | 1983 | 24 | 0.010 |
Why?
|
| Hypothermia, Induced | 1 | 1988 | 754 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2001 | 20169 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1993 | 3684 | 0.010 |
Why?
|
| Injections | 1 | 2006 | 839 | 0.010 |
Why?
|
| Animal Feed | 1 | 2002 | 105 | 0.010 |
Why?
|
| Erythrocytes | 2 | 1989 | 2411 | 0.010 |
Why?
|
| Employment | 1 | 1989 | 1110 | 0.010 |
Why?
|
| Uterine Neoplasms | 1 | 1991 | 1424 | 0.010 |
Why?
|
| Electroconvulsive Therapy | 1 | 1988 | 505 | 0.010 |
Why?
|
| Ibuprofen | 1 | 1983 | 228 | 0.010 |
Why?
|
| Isomerism | 1 | 2002 | 197 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2002 | 6966 | 0.010 |
Why?
|
| 3-Hydroxybutyric Acid | 3 | 1987 | 72 | 0.010 |
Why?
|
| RNA | 1 | 1992 | 2715 | 0.010 |
Why?
|
| Research | 1 | 1990 | 1977 | 0.010 |
Why?
|
| S Phase | 2 | 1994 | 424 | 0.010 |
Why?
|
| Home Care Services | 2 | 1987 | 659 | 0.010 |
Why?
|
| 17-Hydroxycorticosteroids | 1 | 1981 | 38 | 0.010 |
Why?
|
| Escherichia coli Infections | 1 | 1985 | 518 | 0.010 |
Why?
|
| Curriculum | 2 | 2010 | 3786 | 0.010 |
Why?
|
| Gluconeogenesis | 3 | 1988 | 186 | 0.010 |
Why?
|
| Hypothalamus | 1 | 1986 | 1002 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1997 | 18989 | 0.010 |
Why?
|
| Hemothorax | 1 | 1981 | 58 | 0.010 |
Why?
|
| Sulfonamides | 1 | 1991 | 1982 | 0.010 |
Why?
|
| Metabolic Diseases | 1 | 1987 | 684 | 0.010 |
Why?
|
| Plants, Genetically Modified | 1 | 2000 | 113 | 0.010 |
Why?
|
| Mediastinal Diseases | 1 | 1981 | 91 | 0.010 |
Why?
|
| Diarrhea | 1 | 1987 | 1319 | 0.010 |
Why?
|
| Wound Healing | 1 | 1991 | 2800 | 0.010 |
Why?
|
| Clostridium Infections | 1 | 1987 | 562 | 0.010 |
Why?
|
| Lipid Mobilization | 2 | 1976 | 17 | 0.010 |
Why?
|
| Algorithms | 2 | 1993 | 14098 | 0.010 |
Why?
|
| Transcription Factors | 1 | 1999 | 12158 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1988 | 4855 | 0.010 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1986 | 1149 | 0.010 |
Why?
|
| Thrombosis | 3 | 1983 | 2954 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 2 | 2002 | 6106 | 0.010 |
Why?
|
| Candida | 2 | 1983 | 171 | 0.010 |
Why?
|
| Radiotherapy | 1 | 1986 | 1500 | 0.010 |
Why?
|
| Phlebitis | 1 | 1979 | 34 | 0.010 |
Why?
|
| Fetus | 1 | 1987 | 1878 | 0.010 |
Why?
|
| Viral Load | 1 | 2008 | 3385 | 0.010 |
Why?
|
| Carbohydrate Conformation | 1 | 1999 | 206 | 0.010 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 1999 | 178 | 0.010 |
Why?
|
| Cardiovascular Agents | 1 | 1985 | 849 | 0.010 |
Why?
|
| Safety | 1 | 2003 | 1157 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2014 | 4859 | 0.010 |
Why?
|
| Anus Diseases | 1 | 1998 | 53 | 0.010 |
Why?
|
| Sodium | 2 | 1980 | 1594 | 0.010 |
Why?
|
| Patient Compliance | 3 | 1992 | 2697 | 0.010 |
Why?
|
| Menstruation Disturbances | 1 | 1978 | 143 | 0.010 |
Why?
|
| Tidal Volume | 2 | 1992 | 519 | 0.010 |
Why?
|
| Pneumothorax | 1 | 1981 | 393 | 0.010 |
Why?
|
| Food Supply | 1 | 2003 | 544 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2000 | 42606 | 0.010 |
Why?
|
| Intestinal Fistula | 1 | 1998 | 146 | 0.010 |
Why?
|
| Students, Medical | 1 | 2010 | 1965 | 0.010 |
Why?
|
| Skin | 1 | 1991 | 4499 | 0.010 |
Why?
|
| Satiation | 1 | 1977 | 84 | 0.010 |
Why?
|
| Developing Countries | 2 | 2003 | 2911 | 0.010 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 1996 | 46 | 0.010 |
Why?
|
| Biological Transport | 2 | 1995 | 2084 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1990 | 6409 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 12536 | 0.010 |
Why?
|
| Diet Therapy | 1 | 1977 | 150 | 0.010 |
Why?
|
| Jejunoileal Bypass | 2 | 1986 | 13 | 0.010 |
Why?
|
| Radioimmunoassay | 2 | 1987 | 861 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 1997 | 208 | 0.010 |
Why?
|
| Dinitrochlorobenzene | 1 | 1975 | 18 | 0.010 |
Why?
|
| Hematoma | 1 | 1981 | 766 | 0.010 |
Why?
|
| Nephritis | 1 | 1977 | 146 | 0.010 |
Why?
|
| Diagnostic Tests, Routine | 1 | 1981 | 788 | 0.010 |
Why?
|
| Seizures | 1 | 1988 | 2996 | 0.010 |
Why?
|
| Prevalence | 1 | 1993 | 15851 | 0.010 |
Why?
|
| Antigens, Fungal | 1 | 1975 | 69 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2007 | 9660 | 0.010 |
Why?
|
| Hepatitis C | 1 | 1985 | 1594 | 0.010 |
Why?
|
| Lymphocytes | 3 | 1981 | 2605 | 0.010 |
Why?
|
| Prealbumin | 3 | 1983 | 259 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 1988 | 3049 | 0.010 |
Why?
|
| Papua New Guinea | 1 | 1994 | 47 | 0.010 |
Why?
|
| Human Growth Hormone | 1 | 1999 | 642 | 0.010 |
Why?
|
| T-Lymphocytes | 2 | 1986 | 10254 | 0.010 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 1989 | 361 | 0.010 |
Why?
|
| Intestinal Obstruction | 1 | 1998 | 433 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1996 | 2168 | 0.010 |
Why?
|
| Mitotic Index | 1 | 1994 | 160 | 0.010 |
Why?
|
| Pulmonary Surfactants | 1 | 1994 | 169 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2001 | 2931 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 1996 | 697 | 0.010 |
Why?
|
| Sampling Studies | 1 | 1994 | 614 | 0.010 |
Why?
|
| Family Practice | 1 | 1976 | 509 | 0.010 |
Why?
|
| Glutathione Peroxidase | 2 | 1984 | 259 | 0.010 |
Why?
|
| Carcinosarcoma | 1 | 1993 | 108 | 0.010 |
Why?
|
| Thromboxane A2 | 1 | 1992 | 87 | 0.010 |
Why?
|
| Reflex, Abnormal | 1 | 1972 | 83 | 0.010 |
Why?
|
| Plasma | 2 | 1987 | 583 | 0.010 |
Why?
|
| Africa | 1 | 1994 | 725 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1997 | 1966 | 0.010 |
Why?
|
| Food Additives | 1 | 1992 | 23 | 0.010 |
Why?
|
| Alopecia | 1 | 1976 | 416 | 0.010 |
Why?
|
| Hypertension | 1 | 1992 | 8615 | 0.010 |
Why?
|
| Tissue Distribution | 2 | 1987 | 2275 | 0.010 |
Why?
|
| Amino Acids, Essential | 1 | 1991 | 26 | 0.010 |
Why?
|
| Floxuridine | 1 | 1991 | 44 | 0.010 |
Why?
|
| Platelet Function Tests | 1 | 1993 | 275 | 0.010 |
Why?
|
| Propidium | 1 | 1991 | 42 | 0.010 |
Why?
|
| Organic Chemicals | 1 | 1992 | 211 | 0.010 |
Why?
|
| Palmitates | 1 | 1991 | 68 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 59980 | 0.010 |
Why?
|
| G2 Phase | 1 | 1991 | 134 | 0.010 |
Why?
|
| Patient Care Planning | 1 | 1976 | 903 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 1993 | 13650 | 0.010 |
Why?
|
| C-Peptide | 1 | 1992 | 443 | 0.010 |
Why?
|
| Lymphocyte Activation | 2 | 1979 | 5499 | 0.010 |
Why?
|
| Demyelinating Diseases | 1 | 1972 | 354 | 0.010 |
Why?
|
| Specialization | 1 | 1974 | 778 | 0.010 |
Why?
|
| Systole | 1 | 1992 | 935 | 0.010 |
Why?
|
| Cardiac Output | 1 | 1992 | 837 | 0.010 |
Why?
|
| Biological Assay | 2 | 1984 | 626 | 0.010 |
Why?
|
| Litter Size | 1 | 1989 | 49 | 0.010 |
Why?
|
| Decanoic Acids | 1 | 1989 | 69 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 1 | 1972 | 540 | 0.010 |
Why?
|
| Diastole | 1 | 1992 | 784 | 0.010 |
Why?
|
| Stearic Acids | 1 | 1989 | 56 | 0.010 |
Why?
|
| G1 Phase | 1 | 1991 | 403 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 1997 | 1733 | 0.010 |
Why?
|
| Oleic Acids | 1 | 1989 | 71 | 0.010 |
Why?
|
| Bicarbonates | 1 | 1990 | 293 | 0.010 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 1989 | 93 | 0.000 |
Why?
|
| Gestational Age | 2 | 1989 | 3618 | 0.000 |
Why?
|
| Electric Impedance | 1 | 1993 | 792 | 0.000 |
Why?
|
| Autopsy | 1 | 1972 | 1011 | 0.000 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 1989 | 86 | 0.000 |
Why?
|
| Risk | 3 | 1986 | 9606 | 0.000 |
Why?
|
| Nitrogen Isotopes | 1 | 1988 | 80 | 0.000 |
Why?
|
| Lethal Dose 50 | 1 | 1988 | 71 | 0.000 |
Why?
|
| Adaptation, Physiological | 3 | 1983 | 1312 | 0.000 |
Why?
|
| China | 1 | 1994 | 2394 | 0.000 |
Why?
|
| India | 1 | 1994 | 2334 | 0.000 |
Why?
|
| Transplantation, Isogeneic | 1 | 1988 | 249 | 0.000 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1988 | 355 | 0.000 |
Why?
|
| Blood | 1 | 1990 | 596 | 0.000 |
Why?
|
| Acid-Base Imbalance | 1 | 1987 | 41 | 0.000 |
Why?
|
| Citrates | 1 | 1987 | 132 | 0.000 |
Why?
|
| Hair Preparations | 1 | 1987 | 33 | 0.000 |
Why?
|
| Nutrition Surveys | 1 | 1994 | 1738 | 0.000 |
Why?
|
| Fractures, Bone | 1 | 1979 | 2062 | 0.000 |
Why?
|
| Isotonic Solutions | 2 | 1978 | 119 | 0.000 |
Why?
|
| Gene Expression | 1 | 1999 | 7587 | 0.000 |
Why?
|
| Peritoneal Neoplasms | 1 | 1993 | 706 | 0.000 |
Why?
|
| Carbon Isotopes | 1 | 1987 | 453 | 0.000 |
Why?
|
| Pentose Phosphate Pathway | 1 | 1987 | 126 | 0.000 |
Why?
|
| Injections, Subcutaneous | 1 | 1988 | 685 | 0.000 |
Why?
|
| Gastroenterostomy | 1 | 1985 | 18 | 0.000 |
Why?
|
| Models, Theoretical | 2 | 1989 | 3561 | 0.000 |
Why?
|
| Recurrence | 1 | 1978 | 8504 | 0.000 |
Why?
|
| Rats, Inbred Lew | 1 | 1988 | 1168 | 0.000 |
Why?
|
| Hysterectomy | 1 | 1991 | 863 | 0.000 |
Why?
|
| Palmitic Acid | 1 | 1986 | 148 | 0.000 |
Why?
|
| Apoptosis | 1 | 2002 | 9513 | 0.000 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 1985 | 28 | 0.000 |
Why?
|
| Prothrombin Time | 1 | 1986 | 117 | 0.000 |
Why?
|
| Hydroxylation | 1 | 1985 | 139 | 0.000 |
Why?
|
| Glucosephosphates | 1 | 1985 | 19 | 0.000 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1978 | 2186 | 0.000 |
Why?
|
| Glucose-6-Phosphate | 1 | 1985 | 29 | 0.000 |
Why?
|
| Apolipoprotein A-I | 1 | 1987 | 305 | 0.000 |
Why?
|
| Lecithins | 1 | 1984 | 16 | 0.000 |
Why?
|
| Administration, Cutaneous | 1 | 1987 | 715 | 0.000 |
Why?
|
| Partial Thromboplastin Time | 1 | 1986 | 203 | 0.000 |
Why?
|
| Breath Tests | 1 | 1986 | 297 | 0.000 |
Why?
|
| Cluster Analysis | 1 | 1992 | 2721 | 0.000 |
Why?
|
| Drug Synergism | 1 | 1989 | 1759 | 0.000 |
Why?
|
| Blood Coagulation Tests | 1 | 1986 | 269 | 0.000 |
Why?
|
| Selenious Acid | 1 | 1984 | 6 | 0.000 |
Why?
|
| Surgical Wound Dehiscence | 1 | 1986 | 215 | 0.000 |
Why?
|
| Drug Contamination | 1 | 1986 | 151 | 0.000 |
Why?
|
| Diseases in Twins | 1 | 1986 | 447 | 0.000 |
Why?
|
| Indocyanine Green | 1 | 1986 | 237 | 0.000 |
Why?
|
| Salmonella enteritidis | 1 | 1983 | 16 | 0.000 |
Why?
|
| False Positive Reactions | 1 | 1986 | 959 | 0.000 |
Why?
|
| B-Lymphocytes | 1 | 1977 | 4787 | 0.000 |
Why?
|
| Vancomycin | 1 | 1987 | 504 | 0.000 |
Why?
|
| Streptokinase | 1 | 1983 | 186 | 0.000 |
Why?
|
| Catheters, Indwelling | 1 | 1986 | 436 | 0.000 |
Why?
|
| Blood Bactericidal Activity | 1 | 1983 | 124 | 0.000 |
Why?
|
| Transcription, Genetic | 1 | 1997 | 7611 | 0.000 |
Why?
|
| Menopause | 1 | 1991 | 1655 | 0.000 |
Why?
|
| Tetanus Toxoid | 1 | 1983 | 188 | 0.000 |
Why?
|
| Antithrombin III Deficiency | 1 | 1983 | 28 | 0.000 |
Why?
|
| Respiration Disorders | 1 | 1986 | 364 | 0.000 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 1986 | 388 | 0.000 |
Why?
|
| Isoleucine | 1 | 1982 | 111 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1986 | 1076 | 0.000 |
Why?
|
| Costs and Cost Analysis | 1 | 1987 | 1666 | 0.000 |
Why?
|
| Blood Chemical Analysis | 1 | 1983 | 434 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 2002 | 26325 | 0.000 |
Why?
|
| Therapeutics | 1 | 1981 | 113 | 0.000 |
Why?
|
| Kidney Function Tests | 1 | 1983 | 683 | 0.000 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1991 | 2843 | 0.000 |
Why?
|
| Pregnancy | 3 | 1989 | 30238 | 0.000 |
Why?
|
| Physical Endurance | 1 | 1983 | 369 | 0.000 |
Why?
|
| Valine | 1 | 1982 | 410 | 0.000 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1986 | 976 | 0.000 |
Why?
|
| Islets of Langerhans | 1 | 1986 | 1350 | 0.000 |
Why?
|
| Thromboembolism | 1 | 1986 | 1003 | 0.000 |
Why?
|
| Uric Acid | 1 | 1985 | 805 | 0.000 |
Why?
|
| Self Care | 1 | 1984 | 800 | 0.000 |
Why?
|
| Body Constitution | 1 | 1979 | 273 | 0.000 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1983 | 1331 | 0.000 |
Why?
|
| Self Administration | 1 | 1979 | 386 | 0.000 |
Why?
|
| Culture Techniques | 1 | 1979 | 529 | 0.000 |
Why?
|
| Blood Platelets | 1 | 1989 | 2464 | 0.000 |
Why?
|
| Fetal Blood | 1 | 1985 | 1361 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 36582 | 0.000 |
Why?
|
| Autoantibodies | 1 | 1986 | 2114 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1972 | 6282 | 0.000 |
Why?
|
| Cell Line | 1 | 1991 | 15567 | 0.000 |
Why?
|
| Glycine | 1 | 1980 | 670 | 0.000 |
Why?
|
| Surgical Wound Infection | 1 | 1986 | 1547 | 0.000 |
Why?
|
| Birth Weight | 1 | 1985 | 2122 | 0.000 |
Why?
|
| Estrogens | 1 | 1983 | 1536 | 0.000 |
Why?
|
| Hepatomegaly | 1 | 1976 | 84 | 0.000 |
Why?
|
| Intubation | 1 | 1976 | 140 | 0.000 |
Why?
|
| Anesthesia | 1 | 1986 | 1595 | 0.000 |
Why?
|
| Periodicity | 1 | 1976 | 347 | 0.000 |
Why?
|
| Pancreatic Ducts | 1 | 1976 | 330 | 0.000 |
Why?
|
| Magnesium | 1 | 1977 | 815 | 0.000 |
Why?
|
| Aftercare | 1 | 1979 | 915 | 0.000 |
Why?
|
| Neurons | 1 | 1972 | 9517 | 0.000 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 1986 | 3114 | 0.000 |
Why?
|
| Pneumonia | 1 | 1983 | 2159 | 0.000 |
Why?
|
| Pancreatectomy | 1 | 1976 | 825 | 0.000 |
Why?
|
| Mortality | 1 | 1981 | 2909 | 0.000 |
Why?
|
| Patient Education as Topic | 1 | 1979 | 2337 | 0.000 |
Why?
|
| Skin Diseases | 1 | 1977 | 1083 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1982 | 11217 | 0.000 |
Why?
|
| Registries | 1 | 1979 | 8351 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 1986 | 12250 | 0.000 |
Why?
|
| Heart Failure | 1 | 1982 | 11877 | 0.000 |
Why?
|